Re. Luthen et al., THE EFFECT OF L-BUTHIONINE-[S,R]-SULFOXIMINE ON THE PANCREAS IN MICE - A MODEL OF WEAKENING GLUTATHIONE-BASED DEFENSE-MECHANISMS, International journal of pancreatology, 16(1), 1994, pp. 31-36
L-Buthionine-[S,R]-Sulfoximine (BSO) decreases glutathione levels in v
arious organs by inhibition of gamma-glutamylcysteine synthetase. We h
ave examined the levels of total glutathione and oxidized glutathione
in the pancreas of mice, as well as serum amylase and pancreatic histo
logy, after BSO administration in two different ways. The injection of
a single dose of BSO (5 mmol/kg body wt) decreased total glutathione
to 10% of the control value. A similar depletion was observed after 24
h of oral administration of a 10 mM BSO solution, without changes in
the levels of oxidized glutathione. BSO-induced pancreatic glutathione
depletion-even if maintained for up to 14 d-did not cause morphologic
al alterations of the pancreas or hyperamylasemia. Thus pancreatic glu
tathione depletion in itself does not lead to pancreatitis, although d
uring development of experimental acute pancreatitis, glutathione depl
etion has been described. BSO might be used in animal models to weaken
the glutathione-based acinar defense mechanisms against oxidant stres
s or to alter other physiologic processes in which glutathione is invo
lved.